Clinical trial
Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
NCT02446002 is registered in ClinicalTrials.gov with USWM, LLC (dba US WorldMeds) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
- Lead sponsor
- USWM, LLC (dba US WorldMeds)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- June 30, 2015
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy